$KYMR Cashflow Statement | Understand Stock

$KYMR

$114.84 +$4.08 (3.68%) Close

$KYMR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Impairment of long-lived assets
Depreciation and amortization
Premiums and discounts on available for sale marketable securities
Loss on disposal of property and equipment
Non-cash research and development expense
Changes in operating assets and liabilities:
Prepaid expenses and other assets
Accounts receivable—due from related party
Accounts receivable
Contract asset
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Operating lease right-of-use assets
Operating lease liabilities
Other non-current assets
Other non-current liabilities

Net cash used in operating activities
Investing activities
Purchase of property and equipment, net
Purchase of marketable securities
Maturities of marketable securities
Net cash provided by (used in) investing activities
Financing activities
Issuance of common stock and accompanying pre-funded warrants from January 2024 public offering, net of issuance costs of $14.9 million
Proceeds from issuance of common stock through At-The Market Sales Agreement, net of issuance costs of $1.2 million
Issuance of common stock and accompanying pre-funded warrants from August 2024 public offering, net of issuance costs of $12.2 million
Proceeds from 2022 issuance of common stock and accompanying pre-funded warrants from private placement, net of issuance costs of $0.2 million
Proceeds from the issuance of Convertible Preferred Stock, net of issuance costs
Issuance of common stock from December 2025 public offering, net of issuance costs of $36.2 million
Proceeds from stock option exercises
Payments of offering costs in connection with initial public offering
Issuance of common stock and accompanying pre-funded warrants from June 2025 public offering, net of issuance costs of $15.7 million
Proceeds from employee stock purchase plan
Payments on financing leases
Proceeds from follow-on public offering, net of underwriting discounts and offering costs
Proceeds from initial public offering, net of underwriting discounts and offering costs
Proceeds from concurrent private placement
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow activities
Right-of-use assets obtained in exchange for operating lease liabilities
Cash paid for interest
Supplemental disclosure of noncash operating activities
Reduction of right-of-use asset and liability due to lease modification
Supplemental disclosure of noncash investing and financing activities
Purchases of property and equipment through finance and lease liabilities
Property and equipment purchases included in accounts payable and accrued expenses
Offering costs included in accounts payable

Cash and cash equivalents
Restricted cash

Comments